Literature DB >> 19540581

The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF.

Sean M Anderson1, Tom T Chen, M Luisa Iruela-Arispe, Tatiana Segura.   

Abstract

Growth factors are a class of signaling proteins that direct cell fate through interaction with cell-surface receptors. Although a myriad of possible cell fates stems from a growth factor binding to its receptor, the signaling cascades that result in one fate over another are still being elucidated. One possible mechanism by which nature modulates growth factor signaling is through the method of presentation of the growth factor--soluble or immobilized (matrix bound). Here we present the methodology to study signaling of soluble versus immobilized VEGF through VEGFR-2. We have designed a strategy to covalently immobilize VEGF using its heparin-binding domain to orient the molecule (bind) and a secondary functional group to mediate covalent binding (lock). This bind-and-lock approach aims to allow VEGF to assume a bioactive orientation before covalent immobilization. Surface plasmon resonance (SPR) demonstrated heparin and VEGF binding with surface densities of 60 ng/cm2 and 100 pg/cm2, respectively. ELISA experiments confirmed VEGF surface density and showed that electrostatically bound VEGF releases in cell medium and heparin solutions while covalently bound VEGF remains immobilized. Electrostatically bound VEGF and covalently bound VEGF phosphorylate VEGFR-2 in both VEGFR-2 transfected cells and VEGFR-2 endogenously producing cells. HUVECs plated on VEGF functionalized surfaces showed different morphologies between surface-bound VEGF and soluble VEGF. The surfaces synthesized in these studies allow for the study of VEGF/VEGFR-2 signaling induced by covalently bound, electrostatically bound, and soluble VEGF and may provide further insight into the design of materials for the generation of a mature and stable vasculature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540581      PMCID: PMC2826152          DOI: 10.1016/j.biomaterials.2009.05.030

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  35 in total

1.  Selective immobilization of proteins to self-assembled monolayers presenting active site-directed capture ligands.

Authors:  Christian D Hodneland; Young-Sam Lee; Dal-Hee Min; Milan Mrksich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells.

Authors:  B K Mann; R H Schmedlen; J L West
Journal:  Biomaterials       Date:  2001-03       Impact factor: 12.479

3.  Covalently conjugated VEGF--fibrin matrices for endothelialization.

Authors:  A H Zisch; U Schenk; J C Schense; S E Sakiyama-Elbert; J A Hubbell
Journal:  J Control Release       Date:  2001-05-14       Impact factor: 9.776

4.  Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth.

Authors:  Andreas H Zisch; Matthias P Lutolf; Martin Ehrbar; George P Raeber; Simone C Rizzi; Neil Davies; Hugo Schmökel; Deon Bezuidenhout; Valentin Djonov; Peter Zilla; Jeffrey A Hubbell
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

5.  VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.

Authors:  Lukas J A C Hawinkels; Kim Zuidwijk; Hein W Verspaget; Eveline S M de Jonge-Muller; Wim van Duijn; Valérie Ferreira; Ruud D Fontijn; Guido David; Daniel W Hommes; Cornelis B H W Lamers; Cornelis F M Sier
Journal:  Eur J Cancer       Date:  2008-08-06       Impact factor: 9.162

6.  Heparin binds to the laminin alpha4 chain LG4 domain at a site different from that found for other laminins.

Authors:  Hironobu Yamashita; Konrad Beck; Yasuo Kitagawa
Journal:  J Mol Biol       Date:  2004-01-30       Impact factor: 5.469

7.  Immobilized cytokines as biomaterials for manufacturing immune cell based vaccines.

Authors:  Claude Leclerc; Claudia Brose; Clémence Nouzé; Fransisca Leonard; Laleh Majlessi; Sybille Becker; Hagen von Briesen; Richard Lo-Man
Journal:  J Biomed Mater Res A       Date:  2008-09-15       Impact factor: 4.396

8.  Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity.

Authors:  Errol S Wijelath; Jacqueline Murray; Salman Rahman; Yatin Patel; Atsushi Ishida; Kurt Strand; Salim Aziz; Carlos Cardona; William P Hammond; Geoffrey F Savidge; Shahin Rafii; Michael Sobel
Journal:  Circ Res       Date:  2002-07-12       Impact factor: 17.367

Review 9.  Platelet endothelial cell adhesion molecule in cell signaling and thrombosis.

Authors:  NanLing Gong; Subroto Chatterjee
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

10.  Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer.

Authors:  Karen L Christman; Vimary Vázquez-Dorbatt; Eric Schopf; Christopher M Kolodziej; Ronald C Li; Rebecca M Broyer; Yong Chen; Heather D Maynard
Journal:  J Am Chem Soc       Date:  2008-12-10       Impact factor: 15.419

View more
  25 in total

1.  Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.

Authors:  Tania R Chan; Patrick J Stahl; S Michael Yu
Journal:  Adv Funct Mater       Date:  2011-11-22       Impact factor: 18.808

2.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

3.  Targeting collagen strands by photo-triggered triple-helix hybridization.

Authors:  Yang Li; Catherine A Foss; Daniel D Summerfield; Jefferson J Doyle; Collin M Torok; Harry C Dietz; Martin G Pomper; S Michael Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

4.  Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis.

Authors:  Jaclyn A Shepard; Farrukh R Virani; Ashley G Goodman; Timothy D Gossett; Seungjin Shin; Lonnie D Shea
Journal:  Biomaterials       Date:  2012-07-15       Impact factor: 12.479

Review 5.  Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

6.  Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation.

Authors:  Tracy J Puccinelli; Paul J Bertics; Kristyn S Masters
Journal:  Acta Biomater       Date:  2010-04-14       Impact factor: 8.947

Review 7.  Engineering Approaches to Study Cellular Decision Making.

Authors:  Pamela K Kreeger; Laura E Strong; Kristyn S Masters
Journal:  Annu Rev Biomed Eng       Date:  2018-01-12       Impact factor: 9.590

8.  Rac1 GTPase silencing counteracts microgravity-induced effects on osteoblastic cells.

Authors:  Alain Guignandon; Céline Faure; Thibaut Neutelings; Aline Rattner; Pierre Mineur; Marie-Thérèse Linossier; Norbert Laroche; Charles Lambert; Christophe Deroanne; Betty Nusgens; René Demets; Alain Colige; Laurence Vico
Journal:  FASEB J       Date:  2014-06-05       Impact factor: 5.191

9.  Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain.

Authors:  Pouria Moshayedi; Lina R Nih; Irene L Llorente; Andrew R Berg; Jessica Cinkornpumin; William E Lowry; Tatiana Segura; S Thomas Carmichael
Journal:  Biomaterials       Date:  2016-08-02       Impact factor: 12.479

10.  Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds.

Authors:  Steven R Caliari; Brendan A C Harley
Journal:  Tissue Eng Part A       Date:  2013-01-04       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.